The Facilities
Supporting Facilities

The Center for Craniofacial Regeneration

Based at the University of Pittsburgh School of Dental Medicine and the McGowan Institute for Regenerative Medicine, a program of the University of Pittsburgh and the University of Pittsburgh Medical Center, the Center for Craniofacial Regeneration is comprised of a diverse team of clinicians, basic scientists, and clinical researchers. The Center’s focus is to engineer mineralized tissues using cells, biomaterials, and signaling molecules.


McGowan Institute for Regenerative Medicine

What is Regenerative Medicine? Regenerative medicine uses clinical procedures to repair or replace damaged or diseased tissue and organs vs. some of the traditional therapies that are designed to just treat the symptoms. This emerging field uses tissues engineering, stem cell research, medical devices, or combinations of these technologies to address disease and illness. As a pioneer in regenerative medicine, the McGowan Institute develops and transfers science to innovative clinical protocols and pursues rapid commercialization of its technologies related to regenerative medicine.
Learn more about regenerative medicine  

Thomas E. Starzl Transplantation Institute

The leading resource dedicated to helping people from around the world with end-stage organ failure, the Thomas E. Starzl Transplantation Institute was established in 1985 as the Pittsburgh Transplantation Institute. It was renamed in 1996 in honor of Thomas E. Starzl, MD, PhD, whose foresight, perseverance, and commitment made him the modern-day father of organ transplantation.

The mission of the Thomas E. Starzl Transplantation Institute is to foster a multidisciplinary approach to the continual improvement of the clinical, scientific, and social aspects of transplantation to improve the lives of patients with end-stage organ failure. The Starzl Transplantation Institute places a strong emphasis on the advancement of basic science and clinically applied research, and the teaching and training of multinational specialists.

The Starzl Transplantation Institute's transplant team has a tradition of caring for some of the most medically compromised patients. Nevertheless, the institute has maintained patient and graft survival rates that are significantly higher than the national average (this statistic comes from an analysis by The United Network for Organ Sharing).